Images
More than 200 regional, national and international media have echoed the research performed by IDIBAPS and IRB Barcelona scientists and recently published in Nature Communications.
In the study—co-led by Cristina Fillat, head of the Gene Therapy and Cancer Group at IDIBAPS, and Raúl Méndez, ICREA researcher at IRB Barcelona—they have designed a new strategy to achieve genetically modified viruses that selectively attack tumor cells without affecting healthy tissues.
View video:
Link to BTV
Other media mentions
Link to El Periódico
Link to El Mundo
Link to Diari Ara
Link to The Science Times
Link to labiotech.eu
Link to Invisiverse
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
